Search for: "In Re: Schering Plough Corp."
Results 61 - 74
of 74
Sorted by Relevance
|
Sort by Date
17 Feb 2012, 11:29 am
Schering-Plough Corp., 842 A.2d 174, 177-78 (N.J. [read post]
28 Jun 2007, 10:16 am
Schering-Plough Corp., 842 A.2d 174, 178 (N.J. [read post]
23 Jul 2007, 6:58 am
Schering-Plough, 842 A.2d 174 (N.J. [read post]
17 Apr 2008, 10:39 am
March 25, 2008) ("the Court may take judicial notice of and consider the public records of the FDA, such as the Public Health Advisory"); Schering-Plough Healthcare Products, Inc. v. [read post]
12 Apr 2012, 10:56 am
Oct. 7, 2009) (“[m]erely alleging that [defendant] marketed the drugs at issue for off-label purposes does not state a claim for fraud”); In re Schering-Plough Corp. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
21 Apr 2010, 12:08 pm
” Schering-Plough Healthcare Products, Inc. v. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on… [read post]
4 Feb 2008, 8:23 am
Schering-Plough Corp., No. 06-06823, 2007 WL 1839789 (N.D. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
3 Apr 2009, 7:23 pm
Cinram International Inc (Property, intangible) USPTO rules for Smith & Nephew in suture patent fight with Arthrex (Law360) USPTO issues mixed decision in re-examination of patent at the centre of battle between Widevine and Verimatrix (Law360) Supreme Court asked to expand defences to patent infringement: IGT v Aristocrat Tech of Australia (on petition for certiorari) (Patently-O) CAFC to hear oral argument in Erbe Elektromedizin GmbH v ITC on 3 April (ITC 337 Law Blog) Tafas v… [read post]
28 Oct 2011, 7:00 am
Schering Corp., 606 A.2d 1140, 1148, 1150 (N.J. [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
